Skip to content
Facebook-f Twitter
KAOHOON INTERNATIONAL
  • Thailand
  • SET Index
  • Asia
  • USA
  • |
  • Markets
  • Economics
  • Wealth
  • Technology
  • Politics
  • Opinion
  • Sustainability
Trending News
November 6, 2026
KCE Records 63% Net Profit Growth in 3Q26 as Price Adjustments-FX Gains Offset Supply Bottlenecks
November 6, 2026
BCP Reports Stellar 3Q26 Performance as Net Profit Jumps Near 800%, Driven by Refinery and Upstream Businesses
November 6, 2026
North East Rubber Delivers 57% Net Profit Growth in 3Q26 on Strong Domestic Sales and Margin Expansion
November 6, 2026
South Korean Equities Hit Hard as AI Rout Deepens Following US Election Results
Home
/
COVID
/
Page 3
Posted 09/06/2022

Fears Strike Shanghai Residences as Authorities Will Lockdown Saturday for Mass Covid Test

Shanghai will lock down a district in the south-west area on Saturday morning to...

Posted 27/05/2022

Chinese Industrial Profits Rose by 3.5% in April amid Virus Restrictions

Chinese industrial firm's profit fell at their fastest pace in two years in April...

Posted 17/01/2022

China’s Zero-COVID Policy Could Potentially Lead to Prolonged Disruptions in Supply Chain, says Moddy’s

China’s strict zero-COVID policy could lead another prolonged supply chain disruption, according to an...

Posted 22/12/2021

Singapore Freezes Quarantine Free Travel amid Rising Cases of Omicron Globally

Singaporean Health Ministry in a statement announced to freeze quarrantine free travel into the...

Posted 14/12/2021

Pfizer Vaccine Prevents 70% of Hospitlizations of Omicron’s Cases

New South African study shows, Pfizer vaccine prevents 70% of hospitlizations

Posted 07/12/2021

GSK-Vir Drug Works Against All Omicron mutations, Says GSK

British drugmaker on Tuesday said, its drug works against all mutations of the omicron...

Posts navigation

Prev Prev 1 2 3 4 Next Next

TOP NEWS OF THE WEEK

© KAOHOON. All Rights Reserved.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, it is assumed that you accept our Privacy policy.Accept and Close